Main
>
NEUROLOGY.
>
Multiple Sclerosis
>
Treatment
>
AlemtuzuMAb (Anti CD52 MAb)
AlemtuzuMAb (Anti CD52 MAb)'s subsections
Co.: USA. G. (Phase III/Patent)
AlemtuzuMAb (Anti CD52 MAb)'s products
This section has no products